United States of America
Christine Silverstein , Vice President, Investor Relations, Vice President, Investor Relations, joined the company in May of 2016. Prior to her current position, Silverstein was a Director of Investor Relations at Relmada Therapeutics, Inc. a clinical stage, publicly traded specialty pharmaceutical company. Additionally, she served as a Managing Director at SCO Financial Group, a New York based corporate advisory firm and held senior positions at both The Investor Relations Group and Corporate Profile LLC, two boutique investor and public relations firms, where she consulted C-level management on capital markets strategies, media, fundraising initiatives, and regulatory issues. Silverstein brings with her over 15 years of experience in financial and business matters across a wide range of industries, including healthcare. Furthermore, she began her career in the financial services industry as a financial advisor for Royal Alliance Associates. Christine holds a B.S. from the Peter Tobin College of Business, St. John’s University.
Investor Relations,financial and business matters